Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Circle's core product, USDC, benefits from network effects, regulatory positioning and payments tie-ins. Competing stablecoins increase overall demand for dollar-denominated tokens rather than eroding Circle's business one-for-one. This trade idea outlines a long entry in CRCL, with strict risk controls, based on a thesis that modular growth in cus…
Ascent Industries (ACNT) is a $138M market-cap specialty-chemicals company trading at $15.29. Low debt, an enterprise value of ~$91.5M, and an EV/Sales of 1.2 give the stock room to rerate if management can convert revenue into positive free cash flow and stabilize margins. This trade targets a breakout above the 52-week high with a defined stop an…
Greenbrier offers a combination of cheap valuation (P/E ~14.5, P/B ~0.98, EV/EBITDA ~10.9) and a reliable dividend (48 consecutive quarterly payments) that creates a sizeable margin of safety for patient investors. Balance sheet liquidity and improving operating momentum argue for a long trade, while negative free cash flow and leverage represent t…
IBM plunged after a surprise weakness in its Z mainframe business, but the stock now trades near the 52-week low with a 3%+ yield, healthy free cash flow and an attractive risk/reward for long-term holders who can stomach near-term execution risk. This trade idea lays out an entry at $212.66, a stop at $198.00 and a 180-trading-day target of $280.0…
ASML sits at the center of the AI infrastructure build-out. Recent results show accelerating revenue and a 2026 guide lift to €43-45B, while management is committing to a 30% capacity increase now (with another potential 30% in 2028). That combination of structural demand and supply-constrained positioning supports a long trade with a 180-trading-d…
Assembly Biosciences (ASMB) offers a way to play a concentrated biotech bet with a strong strategic partner. With positive Phase 1b readouts for two long-acting helicase-primase inhibitors, a Gilead collaboration, and cash into 2028, the stock ($26.81) already discounts some risk but not all of the upside from Phase 2 starts and potential deal flow…
Redwire (RDW) has been punished since its late-May peak as an announced $500M at-the-market offering and sector rotation into SpaceX hammered the stock. At roughly $8.50 and a $2.02B market cap, the company still shows strong top-line momentum and a sizable backlog, while balance-sheet leverage is manageable. This is a tactical long with tight risk…
Amazon’s core secular story hasn’t changed: AWS continues to scale infrastructure revenue and margins while retail and ads provide durable cash flow. At a market cap of roughly $2.66T and a P/E near 29, the stock still prices in execution but not the next leg of AWS margin expansion. This trade idea outlines a practical long with an entry at $246.0…
Zeta Global is one of the few AI-first marketing software companies showing both rapid revenue growth and measurable free cash flow. With a market cap near $5.4B, improving technicals, a strategic Palantir partnership, and FCF of $183.8M, ZETA looks actionable on a breakout with a disciplined stop. This trade idea lays out entry, stop, targets, cat…
<p>Acco Brands (ACCO) trades at bargain multiples, throws off free cash flow of roughly $49M, and yields over 7% — metrics that argue for a constructive long trade on weakness. The company is small-cap, levered, and exposed to cyclical end markets, so position sizing and a clear stop are essential. This idea targets a measured rebound toward prior …
Santos offers asymmetric upside from exposure to LNG and Asian gas markets, advantaged low-cost production in Australia and a string of near-term growth catalysts. We outline a long-term trade with precise entry, stop and target levels, plus the key risks that could derail the thesis.
WeRide has been named one of China's top 10 AI international cooperation case studies due to its successful deployment of fully driverless Robotaxi services in the UAE. The company is the only autonomous driving firm on the list, showcasing its leadership in commercializing autonomous mobility globally. Operating in multiple UAE emirates with exten…
BJ's Restaurants (BJRI) has ripped to fresh 52-week highs on heavy volume, but the move is backed by solid profitability, healthy free cash flow and a conservative balance sheet. The stock looks actionable on a mid-term (45 trading days) swing with a clear entry, stop and target that balances momentum with valuation discipline.
Five Star Bancorp declared a quarterly cash dividend of $0.25 per share payable on August 10, 2026, to shareholders of record as of August 3, 2026. The company continues to expand its footprint with the opening of a new branch in Lodi, California, indicating growth and stability.
MKDWELL Tech Inc., listed on Nasdaq (MKDW), has announced the acquisition of Landvision Inc., a developer of AI-enabled smart-home and IoT products. This acquisition will diversify MKDWELL's business from automotive electronics to the growing smart-home sector, leveraging complementary strengths in embedded electronics and manufacturing. The deal i…
Erasca has the science, a modality-agnostic RAS/MAPK pipeline and fresh capital. Recent legal and clinical setbacks pushed sentiment into the gutter; that creates a trading opportunity for investors willing to take event risk. This trade targets a mid-term recovery if the company executes on clinical updates and the patent dispute does not derail d…
Exodus Movement, Inc. announced a strategic operating realignment involving a 25% reduction in its global workforce to align costs and priorities towards developing a comprehensive card issuance and payment platform. The company expects $10-$13 million in annualized savings starting 2027, while continuing to integrate recent acquisitions Monavate a…
DBV Technologies, a late-stage biopharmaceutical company, filed an automatically effective shelf registration statement with the SEC to refresh its at-the-market (ATM) offering program, allowing sales of up to $150 million in American Depositary Shares. The proceeds from this equity sale will primarily be used for manufacturing expansion, developme…
XPO's operational rebound in North American LTL, durable free cash flow, and visible AI-driven productivity gains make it a constructive long-term trade. Valuation is not cheap, but the combination of improving operating ratios, a $456M free cash flow run-rate and bullish technicals supports a long entry at current levels for a 180-trading-day hori…
Alpha Compute Corp., a leading AI GPU infrastructure company, announced the appointment of Enzo Villani as President effective July 16, 2026. Villani will expand his role to oversee corporate strategy, capital allocation, and operations, while continuing as Executive Chairman and Chief Investment Officer. The company does not anticipate changes to …
WISeKey International Holding Ltd filed a Form F-4 registration statement with the U.S. SEC to facilitate its proposed redomiciliation from Switzerland to the British Virgin Islands through a merger between WISeKey and its wholly owned subsidiary WISeKey BVI. The merger will result in WISeKey BVI becoming the publicly traded parent company. The tra…
Zentalis Pharmaceuticals announced two upcoming presentations at the ESMO Congress 2026 highlighting the overall survival results from their DENALI Part 1b study of azenosertib, a first-in-class WEE1 inhibitor targeting Cyclin E1-positive platinum-resistant ovarian cancer. The data supports ongoing late-stage clinical development and regulatory str…
Royalty Pharma plc declared a dividend of $0.235 per Class A ordinary share for the third quarter of 2026, payable on September 10, 2026, to shareholders of record as of August 14, 2026. The company remains a leading acquirer and funder within the biopharmaceutical royalties sector, with a diverse portfolio of royalties on top-selling and developme…
Helport AI Limited announced receipt of a Nasdaq notification indicating that its stock price has been below the $1.00 minimum bid price requirement for 30 consecutive business days. The company has 180 days to restore compliance to maintain its Nasdaq listing. The notice is administrative with no immediate effect on trading. Helport AI remains foc…
Immuneering Corporation announced the granting of inducement stock option awards to its newly appointed Chief Financial Officer, Andrew Gengos, and a non-executive employee. The options are part of the company's 2025 Employment Inducement Award Plan and are intended to incentivize service and align interests with shareholders. The company is focuse…
